Type
Business expansion
Country
Italy
Region
Centro (IT); Lazio; Rieti
Location of affected unit(s)
Rieti
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.20 - Manufacture of pharmaceutical preparations

150 jobs
Number of planned job creations
Job creation
Announcement Date
3 October 2024
Employment effect (start)
3 October 2024
Foreseen end date

Description

Takeda, a Japanese pharmaceutical company, announced the creation of 150 new jobs at its Rieti production plant in Italy. The investment, part of a €350 million five-year plan launched in 2021, culminated in the opening of the new biotech facility in October 2024.

The expansion is driven by Takeda's strategic focus on digitalisation, automation and sustainability, aimed at boosting the production capacity of plasma‑derived therapies and meeting the growing global demand.

All 150 new positions will be located at the Rieti site.

Takeda operates eight industrial sites worldwide, with the Rieti plant hosting over 750 employees and the Pisa plant adding another 250, making around 1,000 employees in the two Italian facilities.


Sources

Citation

Eurofound (2024), Takeda, Business expansion in Italy, factsheet number 204011, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/204011.